Tuesday, June 16, 2026

Kim Jong-un to Make Rare Visit to China as Global Stakes and Tensions Rise

Minister Cho Hyun discusses Kim Jong Un's China visit, North Korea's international engagement, and South Korea's diplomatic strategies.

Incheon Ministry on High Alert After Bomb Threat Demands 3 Million Yen Ransom

Authorities have initiated an investigation after a threatening letter was received by an agency under the Ministry of Environment in Incheon.

PACIFIC DEFENSE COLLAPSE : The Mad Dictator’s Golden Opportunity As THAAD Vanishes To The Middle East

U.S. concerns rise over THAAD redeployment from South Korea to the Middle East amid North Korea's threats, questioning defense readiness.

Tag: Lirafugratinib

HLB’s Liraglutide: A Game-Changer in Cholangiocarcinoma Treatment with FDA Priority Review

HLB's Elevar Therapeutics receives FDA Priority Review for lirafugratinib, a promising treatment for cholangiocarcinoma with a 47% response rate.

HLB Group Unveils Groundbreaking Cancer Treatments at AACR 2026: What You Need to Know

HLB Group will present key findings on anti-cancer therapies at AACR 2026, highlighting SynKIR-110 and Lirafugratinib's advancements.

Top News

- Our Sponsors Ad -

Follow us